Compare ZURA & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZURA | FPH |
|---|---|---|
| Founded | 2022 | 2009 |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.4M | 364.6M |
| IPO Year | N/A | 2013 |
| Metric | ZURA | FPH |
|---|---|---|
| Price | $3.71 | $5.16 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 856.3K | 177.0K |
| Earning Date | 05-14-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $110,020,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.40 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $4.60 |
| 52 Week High | $7.25 | $6.64 |
| Indicator | ZURA | FPH |
|---|---|---|
| Relative Strength Index (RSI) | 37.96 | 59.61 |
| Support Level | $3.25 | $4.89 |
| Resistance Level | $4.12 | $5.35 |
| Average True Range (ATR) | 0.25 | 0.16 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 39.50 | 86.91 |
Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Hearthstone. It derives the majority of revenue from the Great Park segment, which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.